BioSpace News Archive

System Provides Real-Time Endoscopic Visible and Near-Infrared Fluorescence Imaging

Curis, Inc. today announced that on October 1, 2018, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase 30,000 shares of Curis common stock to a new employee, with a grant date of October 1, 2018 (the “Q4 2018 Inducement Grant”).

Teva Pharmaceutical Industries Ltd. announced today that it will release its third quarter 2018 financial results on Thursday, November 1, 2018 at 7:00 a.m. ET.

Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, will present data on sulopenem, its novel oral and IV penem antibiotic, in three poster presentations today at IDWeek 2018 in San Francisco.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, will host a webcast and conference call from the 23rd International Annual Congress of the World Muscle Society, on Friday, October 5, 2018 at 8:30 am ET

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, today announced new positive interim data from ASPIRO, the Phase 1/2 clinical trial of AT132 for the treatment of X-linked Myotubular Myopathy (XLMTM)

The James Hoyer law firm is proud to announce that our client Karin Berntsen was named Whistleblower of the Year at the annual Taxpayers Against Fraud awards dinner, in Washington D.C.

Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that seven studies have been selected for poster presentations at the annual symposium of the North American Neuroendocrine Tumor Society (NANETS) taking place in Seattle, Washington, Oct. 4-6, 2018.

Mark October 17th on the calendar. This is the day that Prime Minister Justin Trudeau of Canada will sign a piece of legislation into law that fully legalizes recreational cannabis.

Rafael Holdings, Inc., (NYSE American: RFL), has scheduled its report of fourth quarter and full fiscal year 2018 (the three and twelve months ended July 31, 2018) financial and operational results for Monday, October 15, 2018.